Anna Barnekow, Senior Associate

Profile

I work primarily with business transfers/ M&A.

I assist Swedish and international companies with corporate transfers, capital raising, IPOs, general corporate law matters and matters relating to compliance with capital market regulations.

Språk: English, Swedish

Karriär

2022-

Setterwalls

2021

Oncopeptides AB (publ)

2017-2021

Recipharm AB (publ)

2017

Lund University, LL.M

2015

Kingston University, London

Case

Setterwalls has advised Doktor.se in connection with a share issue of approximately SEK 250 million

Setterwalls advised Sivers Semiconductors in connection with a directed share issue of approximately SEK 95 million

Setterwalls has assisted GomSpace in connection with a directed share issue of SEK 196 million and the refinancing of a credit facility of EUR 18 million

Setterwalls has advised OssDsign in connection with directed share issue of approximately SEK 158 million

Setterwalls has advised Freemelt in connection with a rights issue

Setterwalls has advised Sivers Semiconductors in connection with a directed share issue of approximately SEK 108 million

Setterwalls advised Enzymatica AB (publ) in connection with a rights issue

Setterwalls has advised Flerie in connection with listing on Nasdaq Stockholm

Setterwalls has advised Flerie in connection with directed share issue of approximately SEK 607 million

Setterwalls has assisted Enzymatica AB (publ) in connection with a fully subscribed rights issue

Setterwalls has advised LIDDS AB (publ) in connection with rights issue of approximately SEK 48.6 million

Setterwalls advises Rejlers in connection with the public takeover bid for Eurocon

Setterwalls has advised IRRAS AB in connection with rights issue of approximately SEK 215 million

Setterwalls has assisted Enzymatica AB in connection with a rights issue of SEK 74.7 million

The EU’s proposed AI Act will constitute further significant regulation of innovative digital solutions. How can our experience of the GDPR help us adapt to new requirements in the life sciences sector?

Läs nyhet

What information under Swedish market rules do listed pharmaceutical companies have to provide regarding their operations?